CRUSEKITUG
UNII 6YYC67U8QJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Crusekitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6YYC67U8QJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2956768-50-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6YYC67U8QJ

CAS Registry Number

2956768-50-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CRUSEKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215730

National Cancer Institute reference terminology for clinical and research data.

INN ID

13525

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Crusekitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CRUSEKITUG

Common Names & Synonyms

CRUSEKITUG [INN]

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV4-4*08 (79.4%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT (8.7.14) (26-33.51-57.96-109)) (1-120) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)), (223-217')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-217') (VKAPPA (HOMO SAPIENS IGKV1-12*01 (89.2%) -IGKJ4*01 (91.7%), CDR-IMGT (6.3.12) (27'-32'.50'-52'.89'-100')) (1'-110') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (156'), V101 (194')) (111'-217')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 17A) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL QX002N .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL QX002N .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HUMANIZED MONOCLONAL ANTIBODY